The target that our country researches and develops independently is definite to the curative effect of anticancer drugs

The target that our country researches and develops independently is definite to the curative effect of anticancer drugs
The target that our country researches and develops independently is definite to the curative effect of anticancer drugs
It is reported ' Reporter forest Xun Liu Yang) The small first molecule target that the scientist of our country researched and developed independently has already finished a clinical trial to hydrochloric acid Eike of anticancer drugs for the Buddhist nun. The result of study reveals, the curative effect of this medicine is not inferior to brand medicine Kirgyzstan of international monopoly and does not take the place of the Buddhist nun, and have the advantage of being obvious on security. A few days ago in national clinical oncological conference and 2010 CSCO on the 13th that Beijing hold ' Clinical tumour society of China) At the annual meeting, this research that is in charge of finishing by Sun Yan, academician of Chinese Academy of Engineering and professor of tumour hospital of Chinese Academy of Medical Sciences becomes the focus that the conferee pays close attention to. It is a target of new generation taking growth factor receptor kinase of epidermis as target to anticancer drugs that Eike takes the place of the Buddhist nun with hydrochloric acid, indication of its first is not cellule lung cancer in later period. It is reported, the shellfish of Zhejiang reaches several doctors studying in America returning to the homeland of company of medicine company to research and develop out with great concentration through 8 years in this medicine. A clinical experimental study of this medicine that is just finished has 27 tumour hospitals in the whole country's participation, study and adopt at random, a pair of blind pair of simulation, parallel research approach that contrasts of positive medicine, directly in order to import the lucky and non- for the Buddhist nun as contrasting medicines medicine. This research is opened for the first time of large-scale clinical trial of antitumor medicine of our country to go on by importing medicine of patent " The head is correct " Beginning of the controlled study. Studies have suggested hydrochloric acid Eike have disease for the intersection of Buddhist nun and group progress 137 day in issues of median, longer than 102 days when Kirgyzstan does not take the place of Buddhist nun; Disease develop hydrochloric acid of time median Eike 154 day in group for Buddhist nun, longer than Kirgyzstan, take the place of 109 days in group such as Buddhist nun either. In security, Eike is 60.5% for the bad reaction incidence of the Buddhist nun, obviously less than Kirgyzstan and does not take the place of 70.4% of Nicaragua, two groups of rash incidence are 40.0% and 49.2% respectively, suffer from diarrhoea the incidence is 18.5% and 27.6% respectively, it is obvious Eike is superior to Kirgyzstan and does not take the place of the Buddhist nun for the security of Nicaragua. The target has overcome the question that traditional chemotherapy medicine specific difference, poisonous side effect are great to anticancer drugs, praised highly by doctors and patients. At present, the target that the domestic tumour patient uses treatment mainly relies on import to anticancer drugs, costing an arm and a leg, the general patient is difficult to bear. Sun Yan academician say if hydrochloric acid Eike list smoothly for Buddhist nun, price its drop than the import like product by more than 50% probably.


|